AgMedica Bioscience Inc. Announces Strategic Investment in, and Exclusive Canadian Licencing Agreement with, Extraction Technology Company, Herbolea S.r.l.
Chatham, Ontario – October 18, 2018 – AgMedica Bioscience Inc. (“AGMEDICA” or the “Company”), a licensed producer of medicinal cannabis, is pleased to announce a strategic investment in, and exclusive licencing agreement with, Herbolea S.r.l. (“HERBOLEA”) (the “Agreement”), a company focused on the development of Bio-Herbolysis™, a patent-pending, disruptive extraction technology. The unique Bio-Herbolysis™ extraction…Find Out More